{"id":913701,"date":"2025-11-25T10:00:44","date_gmt":"2025-11-25T15:00:44","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/atyr-pharma-inc-sued-for-securities-law-violations-contact-the-djs-law-group-to-discuss-your-rights-atyr-7\/"},"modified":"2025-11-25T10:00:44","modified_gmt":"2025-11-25T15:00:44","slug":"atyr-pharma-inc-sued-for-securities-law-violations-contact-the-djs-law-group-to-discuss-your-rights-atyr-7","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/atyr-pharma-inc-sued-for-securities-law-violations-contact-the-djs-law-group-to-discuss-your-rights-atyr-7\/","title":{"rendered":"aTyr Pharma, Inc. Sued for Securities Law Violations &#8211; Contact the DJS Law Group to Discuss Your Rights \u2013 ATYR"},"content":{"rendered":"<div class=\"mw_release\">\n<p>LOS ANGELES, Nov.  25, 2025  (GLOBE NEWSWIRE) &#8212; <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=v7xrlRCeXtTaDMp4GQ3QXPyVFXdoow5aT3Habnzl2wSZp6DHO7bSCpDccVJSj49h-oYtwwDMFZP69VduwNye-jeq3IULxoK3YJbKvGttLLI=\" rel=\"nofollow\" target=\"_blank\">The DJS Law Group<\/a> reminds investors of a class action lawsuit against aTyr Pharma, Inc. (\u201caTyr\u201d or \u201cthe Company\u201d) (NASDAQ: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=NXDZ6hHi4yNdgvQw7iTzgFp4Vl-vZU4M6VGEcdJ77y8_ZXmVBpbFzmYUP8F-Xy8KfFYVIHYCl7labPRiWKr1unD-3EDPOQnoIwNnAS6ewd8=\" rel=\"nofollow\" target=\"_blank\">ATYR<\/a>) for violations of \u00a7\u00a710(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.<\/p>\n<p>Shareholders who purchased shares of ATYR during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointments. Appointment as lead plaintiff is not required to partake in any recovery.<\/p>\n<p>\n        <strong>CLASS PERIOD:<\/strong> January 16, 2025 to September 12, 2025<\/p>\n<p>\n        <strong>DEADLINE: <\/strong>December 8, 2025<\/p>\n<p>\n        <strong>CASE DETAILS: <\/strong>According to the Complaint, the Company made false and misleading statements to the market. aTyr was overwhelmingly positive in its statements to the market about the efficacy of its drug candidate, Efzofitimod. The Company misled investors about the drug\u2019s potential to help patients completely taper the usage of steroids. Based on these facts, aTyr\u2019s public statements were false and materially misleading throughout the class period.<\/p>\n<p>If you are a shareholder who suffered a loss, <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=VpGMP7H0HVhXme1St-YSwvudjBjuqcTZ1CnKiCftTLejD9s3JDr5ZYRoC9eU9YeTdPNBWXYwPItwUgjnKR9yF-CS8CwWpKQF8EQjRNQ4Qdg=\" rel=\"nofollow\" target=\"_blank\">contact us to participate<\/a>.<\/p>\n<p>\n        <strong>NEXT STEPS FOR SHAREHOLDERS<\/strong>: Once you register as a shareholder who purchased shares during the timeframe listed above, you will be enrolled in a portfolio monitoring software to provide you with status updates throughout the lifecycle of the case. There is no cost or obligation to you to participate in this case.<\/p>\n<p>\n        <strong>WHY DJS LAW GROUP?<\/strong> DJS Law Group\u2019s primary focus is to enhance investor return through balanced counseling and aggressive advocacy. We specialize in securities class actions, corporate governance litigation, and domestic\/international M&amp;A appraisals. Our clients are some of the largest and most sophisticated hedge funds and alternative asset managers in the world. The litigation claims of our clients are extraordinarily valuable assets that demand respect, focus, and results.<\/p>\n<p>\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Cha9bS6R82TC9mt3CZFEAOWX8Zq4A0Fo1ccoJiD0DZoafcojLG78sfGp7XKh9TCXFOpNcuTzfZkoZ5BMciG-kWC7bGwfcL0LytKHElWfuX8=\" rel=\"nofollow\" target=\"_blank\">Join the case<\/a> to recover your losses.<\/p>\n<p>This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.<\/p>\n<p>\n        <strong>CONTACT:<\/strong>\n      <\/p>\n<p>David J. Schwartz<br \/>DJS Law Group<br \/>274 White Plains Road, Suite 1<br \/>Eastchester, NY 10709<br \/>Phone: 914-206-9742<br \/>Email: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=SiWrabqrwGkROwyVMyS0WNB1yKXHfDKk8hpCfJ-pF_g3ZFbVvgtrNVA3XVzjItkrGuZm3kw1rTuhocAyJkc7DO0BRjHXkZ9UL0iKt1uJ1VA=\" rel=\"nofollow\" target=\"_blank\">David@djslawllp.com<\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU5MjExMCM3MjkyMjYyIzIyNTg3Njc=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/YzVhOTkwM2YtMjE1OC00NGNiLWI0NmItZGI0NDg4MjQyOWEwLTEyNzAzMTYtMjAyNS0xMS0yNS1lbg==\/tiny\/DJS-Law-Group.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>LOS ANGELES, Nov. 25, 2025 (GLOBE NEWSWIRE) &#8212; The DJS Law Group reminds investors of a class action lawsuit against aTyr Pharma, Inc. (\u201caTyr\u201d or \u201cthe Company\u201d) (NASDAQ: ATYR) for violations of \u00a7\u00a710(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Shareholders who purchased shares of ATYR during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointments. Appointment as lead plaintiff is not required to partake in any recovery. CLASS PERIOD: January 16, 2025 to September 12, 2025 DEADLINE: December 8, 2025 CASE DETAILS: According to the Complaint, the Company made false and misleading statements to the market. aTyr was overwhelmingly &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/atyr-pharma-inc-sued-for-securities-law-violations-contact-the-djs-law-group-to-discuss-your-rights-atyr-7\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;aTyr Pharma, Inc. Sued for Securities Law Violations &#8211; Contact the DJS Law Group to Discuss Your Rights \u2013 ATYR&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-913701","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>aTyr Pharma, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights \u2013 ATYR - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/atyr-pharma-inc-sued-for-securities-law-violations-contact-the-djs-law-group-to-discuss-your-rights-atyr-7\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"aTyr Pharma, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights \u2013 ATYR - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"LOS ANGELES, Nov. 25, 2025 (GLOBE NEWSWIRE) &#8212; The DJS Law Group reminds investors of a class action lawsuit against aTyr Pharma, Inc. (\u201caTyr\u201d or \u201cthe Company\u201d) (NASDAQ: ATYR) for violations of \u00a7\u00a710(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Shareholders who purchased shares of ATYR during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointments. Appointment as lead plaintiff is not required to partake in any recovery. CLASS PERIOD: January 16, 2025 to September 12, 2025 DEADLINE: December 8, 2025 CASE DETAILS: According to the Complaint, the Company made false and misleading statements to the market. aTyr was overwhelmingly &hellip; Continue reading &quot;aTyr Pharma, Inc. Sued for Securities Law Violations &#8211; Contact the DJS Law Group to Discuss Your Rights \u2013 ATYR&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/atyr-pharma-inc-sued-for-securities-law-violations-contact-the-djs-law-group-to-discuss-your-rights-atyr-7\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-11-25T15:00:44+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU5MjExMCM3MjkyMjYyIzIyNTg3Njc=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/atyr-pharma-inc-sued-for-securities-law-violations-contact-the-djs-law-group-to-discuss-your-rights-atyr-7\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/atyr-pharma-inc-sued-for-securities-law-violations-contact-the-djs-law-group-to-discuss-your-rights-atyr-7\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"aTyr Pharma, Inc. Sued for Securities Law Violations &#8211; Contact the DJS Law Group to Discuss Your Rights \u2013 ATYR\",\"datePublished\":\"2025-11-25T15:00:44+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/atyr-pharma-inc-sued-for-securities-law-violations-contact-the-djs-law-group-to-discuss-your-rights-atyr-7\\\/\"},\"wordCount\":363,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/atyr-pharma-inc-sued-for-securities-law-violations-contact-the-djs-law-group-to-discuss-your-rights-atyr-7\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTU5MjExMCM3MjkyMjYyIzIyNTg3Njc=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/atyr-pharma-inc-sued-for-securities-law-violations-contact-the-djs-law-group-to-discuss-your-rights-atyr-7\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/atyr-pharma-inc-sued-for-securities-law-violations-contact-the-djs-law-group-to-discuss-your-rights-atyr-7\\\/\",\"name\":\"aTyr Pharma, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights \u2013 ATYR - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/atyr-pharma-inc-sued-for-securities-law-violations-contact-the-djs-law-group-to-discuss-your-rights-atyr-7\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/atyr-pharma-inc-sued-for-securities-law-violations-contact-the-djs-law-group-to-discuss-your-rights-atyr-7\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTU5MjExMCM3MjkyMjYyIzIyNTg3Njc=\",\"datePublished\":\"2025-11-25T15:00:44+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/atyr-pharma-inc-sued-for-securities-law-violations-contact-the-djs-law-group-to-discuss-your-rights-atyr-7\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/atyr-pharma-inc-sued-for-securities-law-violations-contact-the-djs-law-group-to-discuss-your-rights-atyr-7\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/atyr-pharma-inc-sued-for-securities-law-violations-contact-the-djs-law-group-to-discuss-your-rights-atyr-7\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTU5MjExMCM3MjkyMjYyIzIyNTg3Njc=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTU5MjExMCM3MjkyMjYyIzIyNTg3Njc=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/atyr-pharma-inc-sued-for-securities-law-violations-contact-the-djs-law-group-to-discuss-your-rights-atyr-7\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"aTyr Pharma, Inc. Sued for Securities Law Violations &#8211; Contact the DJS Law Group to Discuss Your Rights \u2013 ATYR\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"aTyr Pharma, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights \u2013 ATYR - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/atyr-pharma-inc-sued-for-securities-law-violations-contact-the-djs-law-group-to-discuss-your-rights-atyr-7\/","og_locale":"en_US","og_type":"article","og_title":"aTyr Pharma, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights \u2013 ATYR - Market Newsdesk","og_description":"LOS ANGELES, Nov. 25, 2025 (GLOBE NEWSWIRE) &#8212; The DJS Law Group reminds investors of a class action lawsuit against aTyr Pharma, Inc. (\u201caTyr\u201d or \u201cthe Company\u201d) (NASDAQ: ATYR) for violations of \u00a7\u00a710(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Shareholders who purchased shares of ATYR during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointments. Appointment as lead plaintiff is not required to partake in any recovery. CLASS PERIOD: January 16, 2025 to September 12, 2025 DEADLINE: December 8, 2025 CASE DETAILS: According to the Complaint, the Company made false and misleading statements to the market. aTyr was overwhelmingly &hellip; Continue reading \"aTyr Pharma, Inc. Sued for Securities Law Violations &#8211; Contact the DJS Law Group to Discuss Your Rights \u2013 ATYR\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/atyr-pharma-inc-sued-for-securities-law-violations-contact-the-djs-law-group-to-discuss-your-rights-atyr-7\/","og_site_name":"Market Newsdesk","article_published_time":"2025-11-25T15:00:44+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU5MjExMCM3MjkyMjYyIzIyNTg3Njc=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/atyr-pharma-inc-sued-for-securities-law-violations-contact-the-djs-law-group-to-discuss-your-rights-atyr-7\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/atyr-pharma-inc-sued-for-securities-law-violations-contact-the-djs-law-group-to-discuss-your-rights-atyr-7\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"aTyr Pharma, Inc. Sued for Securities Law Violations &#8211; Contact the DJS Law Group to Discuss Your Rights \u2013 ATYR","datePublished":"2025-11-25T15:00:44+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/atyr-pharma-inc-sued-for-securities-law-violations-contact-the-djs-law-group-to-discuss-your-rights-atyr-7\/"},"wordCount":363,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/atyr-pharma-inc-sued-for-securities-law-violations-contact-the-djs-law-group-to-discuss-your-rights-atyr-7\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU5MjExMCM3MjkyMjYyIzIyNTg3Njc=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/atyr-pharma-inc-sued-for-securities-law-violations-contact-the-djs-law-group-to-discuss-your-rights-atyr-7\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/atyr-pharma-inc-sued-for-securities-law-violations-contact-the-djs-law-group-to-discuss-your-rights-atyr-7\/","name":"aTyr Pharma, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights \u2013 ATYR - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/atyr-pharma-inc-sued-for-securities-law-violations-contact-the-djs-law-group-to-discuss-your-rights-atyr-7\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/atyr-pharma-inc-sued-for-securities-law-violations-contact-the-djs-law-group-to-discuss-your-rights-atyr-7\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU5MjExMCM3MjkyMjYyIzIyNTg3Njc=","datePublished":"2025-11-25T15:00:44+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/atyr-pharma-inc-sued-for-securities-law-violations-contact-the-djs-law-group-to-discuss-your-rights-atyr-7\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/atyr-pharma-inc-sued-for-securities-law-violations-contact-the-djs-law-group-to-discuss-your-rights-atyr-7\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/atyr-pharma-inc-sued-for-securities-law-violations-contact-the-djs-law-group-to-discuss-your-rights-atyr-7\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU5MjExMCM3MjkyMjYyIzIyNTg3Njc=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU5MjExMCM3MjkyMjYyIzIyNTg3Njc="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/atyr-pharma-inc-sued-for-securities-law-violations-contact-the-djs-law-group-to-discuss-your-rights-atyr-7\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"aTyr Pharma, Inc. Sued for Securities Law Violations &#8211; Contact the DJS Law Group to Discuss Your Rights \u2013 ATYR"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/913701","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=913701"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/913701\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=913701"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=913701"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=913701"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}